SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
jieli
Lv1
60 积分
2022-09-07 加入
最近求助
最近应助
互助留言
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
1个月前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
3个月前
已完结
Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial
3个月前
已完结
Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA
5个月前
已关闭
Feasibility and tolerability of sintilimab plus anlotinib as the second‐line therapy for patients with advanced biliary tract cancers: An open‐label, single‐arm, phase II clinical trial
5个月前
已完结
Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma
5个月前
已完结
Final results of adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis
6个月前
已关闭
Cancer incidence and mortality in China, 2022
6个月前
已完结
Spatiotemporal quantification of HER2-targeting antibody-drug conjugate bystander activity and enhancement of solid tumor penetration
6个月前
已完结
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
7个月前
已完结
没有进行任何应助
感谢
3个月前
感谢
5个月前
感谢
6个月前
感谢
6个月前
感谢
7个月前
感谢
8个月前
感谢
10个月前
感谢
10个月前
感谢
10个月前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论